Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma-Reference-Cited by-同舟云学术

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

Published:2019-05-30 Issue:22 Volume:380 Page:2104-2115
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Facon Thierry¹,Kumar Shaji¹,Plesner Torben¹,Orlowski Robert Z.¹,Moreau Philippe¹,Bahlis Nizar¹,Basu Supratik¹,Nahi Hareth¹,Hulin Cyrille¹,Quach Hang¹,Goldschmidt Hartmut¹,O’Dwyer Michael¹,Perrot Aurore¹,Venner Christopher P.¹,Weisel Katja¹,Mace Joseph R.¹,Raje Noopur¹,Attal Michel¹,Tiab Mourad¹,Macro Margaret¹,Frenzel Laurent¹,Leleu Xavier¹,Ahmadi Tahamtan¹,Chiu Christopher¹,Wang Jianping¹,Van Rampelbergh Rian¹,Uhlar Clarissa M.¹,Kobos Rachel¹,Qi Ming¹,Usmani Saad Z.¹

Affiliation:

1. From University of Lille, Centre Hospitalier Universitaire (CHU) Lille, Service des Maladies du Sang, Lille (T.F.), Hematology Department, University Hospital Hôtel-Dieu, Nantes (P.M.), Department of Hematology, Hospital Haut Leveque, University Hospital, Pessac (C.H.), Hematology Department, University Hospital, Vandoeuvre lès Nancy (A.P.), Service d’Hématologie, CHU de Toulouse–Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse (M.A.), Department of Hematology, Vendée Hospital, La Roche...

Funder

Janssen Research and Development

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1817249

Cited by 745 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quadruplets in newly diagnosed transplant‐ineligible multiple myeloma;American Journal of Hematology;2024-09-10

2. Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis;Hematology;2024-09-09

3. Proceedings from the First Onco Summit: LATAM Chapter, 19–20 May 2023, Rio de Janeiro, Brazil;Cancers;2024-09-03

4. Efficacy of ixazomib, lenalidomide, dexamethasone regimen in daratumumab‐exposed relapsed/refractory multiple myeloma patients: A retrospective analysis;European Journal of Haematology;2024-08-26

5. Mechanisms of resistance to daratumumab in patients with multiple myeloma;Basic & Clinical Pharmacology & Toxicology;2024-08-26